Menu Back toPerspectives on Real-World Data/Evidence Collection Through Expanded Access During the Covid-19 Pandemic

DIA 2021 Global Annual Meeting

Perspectives on Real-World Data/Evidence Collection Through Expanded Access During the Covid-19 Pandemic

Session Chair(s)

Alison Bateman-House, PhD, MA, MPH

Alison Bateman-House, PhD, MA, MPH

  • Assistant Professor, Division of Medical Ethics, Dept of Population Health
  • NYU Langone Health, United States
A panel of international experts in drug development, patient advocacy, clinical trial design, and bioethics will discuss the role of data from expanded access and its complementary relationship to clinical trial-derived evidence.
Learning Objective : Identify policy challenges that mediate real-world data and clinical trial data collection; Assess evidence-based on real world data collected through expanded access programs; Describe successes and failures of policies based on real- world data in the Covid-19 pandemic.

Speaker(s)

Claudia Hirawat

Panelist

Claudia Hirawat

  • Executive Chair
  • VOZ Advisors, United States
Tom Watson

Panelist

Tom Watson

  • Executive Vice President, Early Access Programs
  • Bionical Emas, United Kingdom
Hayley Belli, PhD

Panelist

Hayley Belli, PhD

  • Assistant Professor
  • New York University School of Medicine, United States